LobbyingOrsini Specialty Pharmacy lobbying by quarter
Orsini Specialty Pharmacy's latest lobbying report covers Q1 2024, at $45K. Its first report covers Q1 2024; the issues it reports most are Health Issues.
Orsini Specialty Pharmacy
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q1 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2024 | $45K | 1 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$45K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Sirona Strategies | $45K | 1 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| KRISTA DROBAC | Schedule C/Sr Advisor, Centers for Medicare/Medicaid Services; Legis. Asst., Sen. Durbin; Fellow, Sen. Stabenow | Q1 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/04/22for Q1 2024 | Sirona Strategies | $45K |
| 24/04/22for Q1 2024 | Sirona Strategies | Under $5,000 |